首页 | 本学科首页   官方微博 | 高级检索  
     

可塑形脱矿骨基质/透明质酸骨泥的制备与细胞相容性
引用本文:张乃丽,张育敏,周 沫,杨 婷,王旭昇,马绍英,徐伟俊,董 丽,李宝兴. 可塑形脱矿骨基质/透明质酸骨泥的制备与细胞相容性[J]. 中国组织工程研究, 2013, 17(47): 8182-8188. DOI: 10.3969/j.issn.2095-4344.2013.47.007
作者姓名:张乃丽  张育敏  周 沫  杨 婷  王旭昇  马绍英  徐伟俊  董 丽  李宝兴
作者单位:中国辐射防护研究院,山西省医用组织库,山西省太原市 030006
基金项目:中国辐射防护研究院青年科技基金资助项目(YQ120807)*
摘    要:背景:应用预制成形的材料修复不规则骨缺损时,常出现材料与骨缺损形状不匹配的问题,制备可任意塑形骨泥对促进不规则骨缺损的愈合具有重要意义。目的:构建可塑形脱钙骨基质/透明质酸骨泥,筛选最佳复合比例并评价其细胞相容性。方法:选取合格供体皮质骨制备脱钙骨基质。分别配置浓度为0.75%,1.5%,3%,4.5%的透明质酸溶液并检测其黏度,以450 mg脱钙骨基质与上述各浓度透明质酸溶液1 mL混合,制备不同比例的脱钙骨基质/透明质酸骨泥。37 ℃条件下将骨泥浸泡在PBS平衡液中,观察其离散时间,筛选最佳复合比例的脱钙骨基质/透明质酸骨泥。应用脱钙骨基质/透明质酸骨泥浸提液培养L-929小鼠成纤维细胞,1,4,7 d采用CCK-8法检测骨泥的细胞毒性。结果与结论:随透明质酸浓度的增加其溶液黏度增大,脱钙骨基质/透明质酸骨泥的离散时间延长,3%浓度的透明质酸与450 mg脱钙骨基质复合制备的骨泥具有良好可塑形能力,离散时间为8 h,为最佳复合比例。脱钙骨基质/透明质酸骨泥浸提液培养L-929小鼠成纤维细胞1,4,7 d的细胞增殖率分别为93.72%,101.65%,97.68%,细胞毒性级别为0或1级。表明脱钙骨基质/透明质酸复合质量比为15∶1制备的骨泥具有良好的可塑形能力及抗离散能力,细胞毒性轻微。

关 键 词:生物材料  材料生物相容性  骨组织构建  可塑形骨泥  脱钙骨基质  透明质酸  黏度  抗离散能力  细胞相容性  骨修复材料  其他基金  

Preparation and cell compatibility of malleable demineralized bone matrix/hyaluronic acid putty
Zhang Nai-li,Zhang Yu-min,Zhou Mo,Yang Ting,Wang Xu-sheng,Ma Shao-ying,Xu Wei-jun,Dong Li,Li Bao-xing. Preparation and cell compatibility of malleable demineralized bone matrix/hyaluronic acid putty[J]. Chinese Journal of Tissue Engineering Research, 2013, 17(47): 8182-8188. DOI: 10.3969/j.issn.2095-4344.2013.47.007
Authors:Zhang Nai-li  Zhang Yu-min  Zhou Mo  Yang Ting  Wang Xu-sheng  Ma Shao-ying  Xu Wei-jun  Dong Li  Li Bao-xing
Affiliation:Medical Tissue Bank, China Institute for Radiation Protection, Taiyuan  030006, Shanxi Province, China
Abstract:BACKGROUND:It is important to prepare a malleable putty to repair irregular bone defects because the preformed bone substitute material cannot suit to bone defects.OBJECTIVE:To prepare malleable demineralized bone matrix/hyaluronic acid putty and to screen out the optimal composite ratio, as well as to evaluate its cell compatibility.METHODS:Demineralized bone matrix was prepared from the cortical bone of healthy donors. The hyaluronic acid was dissolved at concentrations of 0.75%, 1.5%, 3%, 4.5%, and the viscosity of them was measured. Then 450 mg demineralized bone matrix was compounded with 1 mL hyaluronic acid solution to prepare the demineralized bone matrix/hyaluronic acid putty, and the optimal ratio of demineralized bone matrix/hyaluronic acid was screened by the disintegrated time of the putty at 37 ℃. L-929 mouse fibroblasts were cultured in the leaching liquor of demineralized bone matrix/hyaluronic acid, and the cytotoxicity was tested by cell count kit-8 assay at days 1, 4 and 7.RESULTS AND CONCLUSION:With the increase of hyaluronic acid concentration, the viscosity of hyaluronic acid solution was increased; the demineralized bone matrix/hyaluronic acid putty was strengthened and the disintegrated time was prolonged gradually. When the ratio of demineralized bone matrix/hyaluronic acid was 15/1, demineralized bone matrix/hyaluronic acid was molded easily, and the disintegrated time was 8 hours in 7 ℃ PBS. The results of cytotoxicity showed that cell proliferation rates were 93.72%, 101.65% and 97.68% at days 1, 4 and 7 respectively, while the cytotoxicity was in grade 0 or 1. These findings indicate that demineralized bone matrix/hyaluronic acid putty at a compound ratio of 15:1 can be molded easily and difficult to disintegrate, with low cytotoxicity.
Keywords:biocompatible materials  bone matrix  hyaluronic acid  histocompatibility testing  
点击此处可从《中国组织工程研究》浏览原始摘要信息
点击此处可从《中国组织工程研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号